Lataa...
CD137 stimulation enhances the vaccinal effect of anti-tumor antibodies
Some evidence suggests that monoclonal antibodies (mAb) can induce an adaptive immune response against tumor cells (“vaccinal effect”). Recently, we have shown that an anti-CD137 mAb can enhance the “vaccinal effect” of an anti-tumor mAb (cetuximab), thereby transforming a passive, monoclonal, short...
Tallennettuna:
| Julkaisussa: | Oncoimmunology |
|---|---|
| Päätekijät: | , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Taylor & Francis
2014
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4292240/ https://ncbi.nlm.nih.gov/pubmed/25610724 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/21624011.2014.941740 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|